Page last updated: 2024-10-26

etodolac and Skin Neoplasms

etodolac has been researched along with Skin Neoplasms in 2 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Skin Neoplasms: Tumors or cancer of the SKIN.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kapadia, GJ1
Azuine, MA1
Shigeta, Y1
Suzuki, N1
Tokuda, H1
Abo Aasy, NK1
Ragab, D1
Sallam, MA1
Abdelmonsif, DA1
Aly, RG1
Elkhodairy, KA1

Other Studies

2 other studies available for etodolac and Skin Neoplasms

ArticleYear
Chemopreventive activities of etodolac and oxyphenbutazone against mouse skin carcinogenesis.
    Bioorganic & medicinal chemistry letters, 2010, Apr-15, Volume: 20, Issue:8

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Cell Transformation

2010
A comparative study: the prospective influence of nanovectors in leveraging the chemopreventive potential of COX-2 inhibitors against skin cancer.
    International journal of nanomedicine, 2019, Volume: 14

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chemoprevention; Cyclooxygenase 2;

2019